450
Participants
Start Date
April 10, 2018
Primary Completion Date
March 15, 2024
Study Completion Date
December 31, 2024
blood samples
Blood samples
Temple University, Philadelphia
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Temple University
OTHER